Skip to main content
HCPCS J0883 · Level II · Part B drug

J0883: argatroban, non-ESRD, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J0883

Billing unit
1 MG
Argatroban nonesrd use 1mg
ASP payment limit
$0.772
October 2026; -10.7% vs July 2026
Practitioner MUE
1125
MAI 3
OPPS status
SI K
APC 1859
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J0883 is the Level II code for Injection, argatroban, 1 mg (for non-esrd use), billed per 1 MG. The Medicare Part B ASP payment limit for October 2026 is $0.772 per billing unit, down 10.7% from July 2026. The practitioner MUE allows up to 1125 units per date of service (MAI 3), so a full 1125-unit day is $868.50 at the current limit. Under OPPS it carries status indicator K in APC 1859. The descriptor restricts this code to non-ESRD use; the ESRD-on-dialysis counterpart is a separate code and billing the wrong one is a frequent reason for CARC 16 returns. With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. Other HCPCS codes whose descriptor names argatroban: J0884 (for ESRD patients on dialysis); J0899 (for ESRD patients on dialysis; the Auromedics product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0884); J0898 (the Auromedics product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0883). The ASP crosswalk maps 10 NDCs to it, sold as Argatroban by Hikma Pharmaceuticals USA Inc., Sagent Pharmaceuticals, Endo USA, Inc. No current Billing and Coding Article lists J0883, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J0883 at $0.772 per 1 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.864 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J0883
QuarterPayment limitPerCoinsurance
October 2026$0.7721 MG20%
July 2026$0.8641 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 10 NDCs from 7 labelers to J0883. Report the NDC in the claim's drug segment and bill the number of J0883 units that equals the quantity administered divided by 1 MG; the last column gives units per full package.

NDCs that crosswalk to J0883
NDCDrug nameLabelerPackage sizeBilling units / package
00143-9377-01ArgatrobanHikma Pharmaceuticals USA Inc.50 × 150
00143-9559-01ArgatrobanHikma Pharmaceuticals USA Inc.50 × 150
00143-9674-01ArgatrobanHikma Pharmaceuticals USA Inc.2.5 × 1250
25021-0414-50ArgatrobanSagent Pharmaceuticals50 × 150
42023-0182-01ArgatrobanEndo USA, Inc.2.5 × 1250
42023-0182-89ArgatrobanEndo USA, Inc.2.5 × 1250
65145-0126-01ArgatrobanCaplin Steriles USA Inc.50 × 150
65219-0429-50ArgatrobanFreseniUS Kabi USA, LLC50 × 150
67457-0212-02ArgatrobanMylan Institutional LLC2.5 × 1250
83301-0062-01ArgatrobanMullan Pharmaceutical Inc.50 × 150

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J0883. For practitioners the limit is 1125 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J0883 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services11253 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital12503 Date of Service Edit: ClinicalPrescribing Information
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J0883 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J0883 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J0883 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J0883 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J0883 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J0883 carries status indicator K and is assigned to APC 1859, with a published national unadjusted payment of $0.772. Status K means the drug is paid separately under OPPS at the ASP-based rate rather than packaged into the procedure.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J0883 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $0.77 per 1 MG, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for J0883 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J0883

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J0883

What does HCPCS code J0883 describe?

J0883 is defined by CMS as "Injection, argatroban, 1 mg (for non-esrd use)". Each billing unit represents 1 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J0883 a CPT code?

No. J0883 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as argatroban; CPT codes are five-character codes maintained by the AMA. On a Part B claim J0883 reports the drug itself in 1 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J0883 in October 2026?

The ASP-based payment limit is $0.772 per 1 MG, with 20% beneficiary coinsurance. The July 2026 limit was $0.864. Commercial payers use their own fee schedules.

How many units of J0883 can be billed per day?

The practitioner Medically Unlikely Edit is 1125 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 1250. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J0883?

The October 2026 ASP crosswalk lists 10 NDCs from 7 labelers: Argatroban (Hikma Pharmaceuticals USA Inc.); Argatroban (Sagent Pharmaceuticals); Argatroban (Endo USA, Inc.); Argatroban (Caplin Steriles USA Inc.). For example NDC 00143-9377-01 (package size 50) equals 50 billing units of J0883.

Does J0883 have NCCI bundling edits?

No active practitioner PTP pairs list J0883 as a column-1 or column-2 code in the v323r0 release.

J0883 vs J0884: what is the difference?

Both are HCPCS Level II codes whose descriptor names argatroban. What sets J0884 apart: for ESRD patients on dialysis. J0883 is billed per 1 mg, limit $0.772, MUE 1125; J0884 is billed per 1 mg, limit $0.772, MUE 1125. Report the code whose descriptor matches the product and setting in the record.

J0883 vs J0899: what is the difference?

Both are HCPCS Level II codes whose descriptor names argatroban. What sets J0899 apart: for ESRD patients on dialysis; the Auromedics product (manufacturer named in its CMS descriptor); not therapeutically equivalent to J0884. J0883 is billed per 1 mg, limit $0.772, MUE 1125; J0899 is billed per 1 mg, limit $1.206. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.